Shares in Pfizer and Moderna fell 3.9% and 7.4%, respectively, Friday after a report that the Trump administration plans to ...

For U.S. Big Pharma companies, vaccines have largely been an afterthought. But by 2030, they could be a quarter of Pfizer’s ...

Vaccine makers are publicly defending Covid-era achievements as the Trump administration rolls back vaccine approvals and ...

In a post on Truth Social, Trump asserted that he has seen "extraordinary" data from companies such as Pfizer, but criticized ...

Pfizer has demonstrated remarkable financial resilience in its latest quarterly report, significantly outpacing Wall Street expectations across key metrics. The pharmaceutical powerhouse announced ...

New data has ranked all 50 states across three key dimensions including children and teen immunization rates, adult and ...

Pfizer (PFE) stock in focus as the company plans to release new data on its updated COVID vaccine developed with BioNTech ...

Diluted earnings and revenue smashed through Wall Street consensus estimates. Management raised its full-year earnings guidance for 2025. Pfizer is starting to execute on its turnaround plan and drug ...